Researchers Publish Largest Observational Study To-Date Comparing Novel Oral Anticoagulants (NOACs) Pradaxa ® (dabigatran etexilate mesylate) and Rivaroxaban

Source: Boehringer Ingelheim Press Releases - Category: Research Source Type: news
More News: Pradaxa | Research | Study